Average lifespan shortened due to breast cancer in Australia, 1990–2015

Revisiting the Calculation for a Novel Measure of Average Lifespan Shortened: Real-World Examples From Cervical and Ovarian Cancers in Alberta, Canada, 2000 - 2020

“…The measure addresses the specific question of how much earlier patients died than expected. The foundation of the measure and the interpretation of results have been described elsewhere [1][2][3][4][5][6][7][8][9][10][11] and are beyond the scope of the present study. In brief, the novel measure is more comparable than the existing measures of years of life lost, because it takes into consideration the inherent temporal improvement of life expectancy of a given population [1] or the discrepancies of life expectancy across populations [2].…”

“…In brief, the novel measure is more comparable than the existing measures of years of life lost, because it takes into consideration the inherent temporal improvement of life expectancy of a given population [1] or the discrepancies of life expectancy across populations [2]. Since its inception, we have applied the measure to both cancer [1][2][3][4][5][6][7][8][9][10] and noncancer [11] conditions, and have demonstrated that the measure is robust in examining changes in lifespan of patients over time, or in comparing lifespan of patients between health conditions and across populations. However, the calculation of uncertainty of the estimate is not yet available.…”